Keywords: gilead, storz, nucleoside, analogue, drug, sciences, partner

Gilead and Storz test Gilead nucleoside analogue drug

Article | 08 January 1996

Print This

- Gilead Sciences' partner Storz Instrument has begun a Phase I trial of Gilead's nucleotide analogue cidofovir, in an eyedrop formulation, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in